FDA Drug Info Rounds http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm211957.htm en-us U.S. Food and Drug Administration, Center for Drug Evaluation and Research FDA Drug Info Rounds is a series of training videos for practicing clinical and community pharmacists. Center for Drug Evaluation and Research druginfo@fda.hhs.gov (CDER Division of Drug Information) no Wed, 20 Apr 2011 02:30 EDT cderwebmaster@fda.hhs.gov (CDER Webmaster) FDA Drug Info Rounds pharmacists discuss the vital role that pharmacists play in assisting the FDA with communicating drug safety messages. Wed, 20 Apr 2011 02:30 EDT http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm251790.htm http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm251790.htm drug safety, Listserv, drug safety podcasts, drug information, FDA widget, FDA Drug Info Twitter, FDA social media, adverse events, MedWatch. FDA Drug Info Rounds pharmacists discuss FDA's role in responding to and mitigating drug shortages. Wed, 01 Dec 2010 10:24 EDT http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm235347.htm http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm235347.htm drug shortages, drug safey FDA Drug Info Rounds pharmacists discuss FDA's ongoing safety review of adverse event reports in children who may have been unintentionally exposed to the drug through skin contact with women using Evamist. Fri, 01 Oct 2010 08:24 EDT http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm227864.htm http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm227864.htm Evamist, drug safey FDA Drug Info Rounds pharmacists discuss new safety information about a possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors, strengths and limitations of the studies, and recommendations for pharmacists. Mon, 09 Aug 2010 12:55 EDT http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm221672.htm http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm221672.htm Proton Pump Inhibitors, PPIs, fractures Long-Acting Beta-Agonists (LABAs), a class of medications used for the treatment of asthma and chronic obstructive pulmonary disease (COPD), now have new recommendations in their drug label intended to promote their safe use in the treatment of asthma. Mon, 26 Jul 2010 10:00 EDT http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm219161.htm http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm219161.htm Long-Acting Beta-Agnoists, LABAs, asthma, chronic pulmonary disease FDA Drug Info Rounds pharmacists discuss the differences between approved and unapproved colchicine products, concerns regarding unapproved single-ingredient oral colchicine, and how patients can offset the increased cost of Colcrys. Mon, 26 Jul 2010 10:00 EDT http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm211975.htm http://www.fda.gov/Drugs/ResourcesForYou/HealthProfessionals/ucm211975.htm Drug Safety, Colchicine, Colcrys